Medtronic (MDT): In-Line Quarter, Raising PT - Piper Jaffray
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
Go back to Medtronic (MDT): In-Line Quarter, Raising PT - Piper Jaffray
June 1, 2016 8:41 AM EDT
Wedbush reiterated a Neutral rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $82.00 (from $79.00), following the company's 4Q earnings report. MDT reported revenue of $7,567 million, beating the consensus revenue estimate of $7,479 million and was above the upper end of guidance at... More
June 1, 2016 7:49 AM EDT
Leerink Partners reiterated a Market Perform rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $85.00 (from $82.00), following the company's 4Q earnings report. MDT delivered its 6th consecutive quarter of mid- to high-single-digit sales growth, building a consistent track record.
Analyst Danielle Antalffy commented, "MDT shares traded lower yesterday driven by what we believe were expectations of more positive operating leverage than the company delivered, potentially as well as a more... More
May 31, 2016 6:47 AM EDT
Medtronic (NYSE: MDT) reported Q4 EPS of $1.27, $0.01 better than the analyst estimate of $1.26. Revenue for the quarter came in at $7.57 billion versus the consensus estimate of $7.49 billion.
GUIDANCE:
Medtronic sees FY2017 EPS of $4.60-$4.70, versus the consensus of $4.70.
In fiscal... More
